MARIA ISABEL G. V. B.
- Country
- Portugal
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 34 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating biliary tract cancer (BTC), with particular emphasis on advanced and metastatic cases. Their research focuses on innovative therapeutic approaches for patients with HER2-positive biliary tract malignancies.
- Advanced Biliary Tract Cancer Treatment
- HER2-Targeted Therapy
- Combination Treatment Strategies
Their expertise extends to evaluating novel therapeutic combinations including targeted therapies and immunotherapy approaches for biliary tract cancers.
Targeted Therapy Development
The investigator focuses on developing and implementing HER2-directed treatment strategies, particularly exploring the therapeutic potential of novel agents in gastrointestinal cancers.
- HER2-Positive Cancer Treatment
- Novel Therapeutic Agents
- Biomarker-Driven Therapy
Their work involves evaluating personalized treatment approaches based on specific molecular markers in cancer therapy.
Immunotherapy Research
The investigator explores the integration of immune checkpoint inhibition in treatment protocols, specifically investigating PD-1/PD-L1 pathway modulation in combination with other therapeutic approaches.
- Checkpoint Inhibitor Integration
- Combination Immunotherapy
- Advanced Cancer Treatment
Their research encompasses innovative combinations of immunotherapy with conventional chemotherapy and targeted agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.